Stock Screener App

무료 -

설치하다

16.02

0.12% 0.02

Latigo Biotherapeutics, Inc. Common Stock (LTGO)

개요 뉴스 가격 이력 Financials 토론 예측

Latigo Biotherapeutics, Inc. Common Stock 주식(LTGO)의 최신 뉴스

Latigo Biotherapeutics, Inc. Common Stock (NASDAQ: LTGO) Stock Price, News & Analysis - kalkine.ca

Latigo Biotherapeutics, Inc. Common Stock (LTGO) Earnings Reports & Dates - FXEmpire

Latigo Biotherapeutics Q2 Results: EPS loss narrows 24% YoY - scanx.trade

Latigo Biotherapeutics (LTGO) draws 4.45M-share stake from Deep Track - Stock Titan

Sanofi Converts Series B Preferred Stock and Convertible Note into Latigo Biotherapeutics Common Shares Following IPO - Kalkine Media

Latigo Biotherapeutics Completes IPO and Updates Governance - TipRanks

Latigo Biotherapeutics (LTGO) On IPO And Trial Data Looks About Right Valued - Yahoo Finance

Latigo Biotherapeutics (Nasdaq:LTGO)Stock Analysis - Simply Wall Street

Latigo Biotherapeutics Prices Upsized $345.6 Million Initial Public Offering - quiverquant.com

Latham & Watkins Advises on Latigo Biotherapeutics’ Upsized US$345.6 Million Initial Public Offering - Latham & Watkins LLP

Latigo Biotherapeutics Announces Pricing of Upsized $345.6 Million Initial Public Offering - GlobeNewswire

Latigo Biotherapeutics prices $345.6M IPO at $18 per share - Investing.com

Latigo Biotherapeutics files for Nasdaq IPO at up to $18 per share - Investing.com

Latigo Biotherapeutics files for $256M-$288M Nasdaq IPO - scanx.trade

Latigo Biotherapeutics Commences IPO Process For Pain Treatment Pipeline (Pending:LTGO) - Seeking Alpha

MRVI

$7.06

5.11%

IMTX

$7.21

2.96%

AVLN

$24.80

3.73%

JANX

$18.15

1.31%

MNKD

$3.13

4.86%

MGTX

$10.38

2.90%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개